Oct. 4, Lexicon presented more than $300,000 in bonus checks to employees as part of a program started by company found ...

If you’re curious about how to create a secure password, read our in-depth guide covering password security and best ...

Noah Webster was the patriot armed with a pen. He defined 12,000 new words in the wake of the American Revolution, using ...

Lexicon Pharmaceuticals Inc (LXRX) stock saw a modest uptick, ending the day at $1.69 which represents a slight increase of $0.08 or 4.97% from the prior close of $1.61. The stock opened at $1.63 and ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $10.0, a ...

Lexicon Pharmaceuticals (LXRX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Joseph Pantginis from H.C. Wainwright maintained a Buy ...

Summary ・NetEase (NTES) has shown strong technical performance, with a 29.61% increase since the Trend Seeker buy signal on 9 ...

AbbVie is a superbly managed organization. The company's leaders expertly positioned it for Humira's loss of patent protection. However, the shares look pricey at the moment. AbbVie is known as ...

WASHINGTON—Donald Trump grimaced and shook his head as Kamala Harris hurled another insult at their debate, claiming “world leaders are laughing” at him. Asked to respond, the former ...

On Friday, Lexicon Pharmaceuticals Inc (LXRX) stock saw a modest uptick, ending the day at $1.6 which represents a slight increase of $0.06 or 3.90% from the prior close of $1.54. The stock opened at ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Lexicon Pharmaceuticals (LXRX – Research Report) and Travere ...